Goldman Sachs’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215M | Buy |
|
|||||
|
2025
Q1 | $165M | Buy |
|
|||||
|
2024
Q4 | $156M | Sell |
|
|||||
|
2024
Q3 | $185M | Sell |
|
|||||
|
2024
Q2 | $211M | Buy |
|
|||||
|
2024
Q1 | $186M | Buy |
|
|||||
|
2023
Q4 | $120M | Buy |
|
|||||
|
2023
Q3 | $89.2M | Buy |
|
|||||
|
2023
Q2 | $91.2M | Buy |
|
|||||
|
2023
Q1 | $90.8M | Buy |
|
|||||
|
2022
Q4 | $81.9M | Sell |
|
|||||
|
2022
Q3 | $94.9M | Buy |
|
|||||
|
2022
Q2 | $84.1M | Buy |
|
|||||
|
2022
Q1 | $94.8M | Sell |
|
|||||
|
2021
Q4 | $108M | Sell |
|
|||||
|
2021
Q3 | $116M | Buy |
|
|||||
|
2021
Q2 | $89.6M | Buy |
|
|||||
|
2021
Q1 | $67.2M | Sell |
|
|||||
|
2020
Q4 | $76.3M | Sell |
|
|||||
|
2020
Q3 | $82.6M | Sell |
|
|||||
|
2020
Q2 | $97.6M | Sell |
|
|||||
|
2020
Q1 | $79.5M | Sell |
|
|||||
|
2019
Q4 | $99M | Sell |
|
|||||
|
2019
Q3 | $87.7M | Buy |
|
|||||
|
2019
Q2 | $69.9M | Sell |
|
|||||
|
2019
Q1 | $65.7M | Sell |
|
|||||
|
2018
Q4 | $84.8M | Sell |
|
|||||
|
2018
Q3 | $92.3M | Buy |
|
|||||
|
2018
Q2 | $66.9M | Sell |
|
|||||
|
2018
Q1 | $84.5M | Buy |
|
|||||
|
2017
Q4 | $72.5M | Sell |
|
|||||
|
2017
Q3 | $76M | Buy |
|
|||||
|
2017
Q2 | $69.9M | Sell |
|
|||||
|
2017
Q1 | $73.2M | Sell |
|
|||||
|
2016
Q4 | $72M | Buy |
|
|||||
|
2016
Q3 | $75M | Sell |
|
|||||
|
2016
Q2 | $76.3M | Buy |
|
|||||
|
2016
Q1 | $64.9M | Sell |
|
|||||
|
2015
Q4 | $63.8M | Buy |
|
|||||
|
2015
Q3 | $23.6M | Buy |
|
|||||
|
2015
Q2 | $23.8M | Sell |
|
|||||
|
2015
Q1 | $34.5M | Buy |
|
|||||
|
2014
Q4 | $19.5M | Buy |
|
|||||
|
2014
Q3 | $8.3M | Sell |
|
|||||
|
2014
Q2 | $11.1M | Sell |
|
|||||
|
2014
Q1 | $17.5M | Buy |
|
|||||
|
2013
Q4 | $10.1M | Sell |
|
|||||
|
2013
Q3 | $11.9M | Buy |
|
|||||
|
2013
Q2 | $7.65M | Buy |
|